Janus Kinases: Structural Biology Services
The inhibition of the JAK/STAT signaling pathway is a promising approach for the treatment of cancers and inflammatory diseases. To support drug discovery programs, we have established off-the-shelf crystallization systems to enable the determination of high-resolution X-ray crystal structures with a short turnaround time. Together with our protein production service and off-the-shelf biochemical and biophysical assays, we can provide a broad range of data to accelerate and support your drug development programs.
The WuXi AppTec Discovery Biology Structural Biology platform provides a wide range of X-ray crystallography and cryo-EM services. With decades of experience in structural biology and state-of-the-art infrastructure in Munich (Germany) and Suzhou (China), we are the ideal partner for your drug discovery program.
Janus Kinases_Structural Biology Services
Related Content
At the 2024 Protein & Antibody Engineering Summit (PEGS) Europe, Crelux presented a poster highlighting its drug discovery platform for...
VIEW RESOURCEThe ErbB family of receptor tyrosine kinases are involved in key cellular functions, including cell growth and survival. ErbB family...
VIEW RESOURCE